secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001193125-25-233450
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Scilex appoints Stephen Ma as COO; he continues as CFO
------------------------------------------------------

- Stephen Ma, 53, appointed COO effective Oct 1, 2025; retains CFO, SVP, Corporate Secretary, and Board roles.
- Ma has 15+ years finance/operations experience in pharma and venture-backed biotech.
- Also appointed CFO of Semnur Pharmaceuticals (OTC:SMNR) on Sep 22, 2025.
- No change in compensation for his COO appointment; standard indemnification agreement in place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000119312525233450/0001193125-25-233450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000119312525233450/sclx-20251001.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-233450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer